Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Schweizer

Showing results (241-250 of 493) with videos related to

Pageof 50
Sort By:
Frontiers in Human Neuroscience|September 6, 2021
Driving With Distraction: Measuring Brain Activity and Oculomotor Behavior Using fMRI and Eye-TrackingNicole H Yuen, Fred Tam, Nathan W Churchill, et al.
World Journal of Surgery|May 18, 2018
Xiphoidectomy for Intractable XiphodyniaPatrick Dorn, Michael A Kuhn, Barbara A Schweizer, et al.
International Review of Psychiatry (Abingdon, England)|September 24, 2019
Gender role in sleep disturbances among older adults with traumatic brain injuryConor Ledger, Wael K Karameh, David G Munoz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 14, 2012
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Gene|September 25, 2012
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1Parwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
Life Sciences|August 23, 2012
Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunitsJana Kisselbach, Patrick A Schweizer, Rüdiger Gerstberger, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compoundI Wiesenberg-Boettcher, A Schweizer, J R Green, et al.
Journal of Cell Science|March 1, 1993
A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation proteinA Schweizer, J Rohrer, P Jenö, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|May 21, 2011
Bilingualism as a contributor to cognitive reserve: evidence from brain atrophy in Alzheimer's diseaseTom A Schweizer, Jenna Ware, Corinne E Fischer, et al.
European Journal of Pharmacology|September 28, 2013
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Pageof 50

Showing results (241-250 of 493) with videos related to

Sort By:
Pageof 50
Frontiers in Human Neuroscience|September 6, 2021
Driving With Distraction: Measuring Brain Activity and Oculomotor Behavior Using fMRI and Eye-TrackingNicole H Yuen, Fred Tam, Nathan W Churchill, et al.
World Journal of Surgery|May 18, 2018
Xiphoidectomy for Intractable XiphodyniaPatrick Dorn, Michael A Kuhn, Barbara A Schweizer, et al.
International Review of Psychiatry (Abingdon, England)|September 24, 2019
Gender role in sleep disturbances among older adults with traumatic brain injuryConor Ledger, Wael K Karameh, David G Munoz, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|July 14, 2012
Novel electrophysiological properties of dronedarone: inhibition of human cardiac two-pore-domain potassium (K2P) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Gene|September 25, 2012
Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1Parwez Aidery, Jana Kisselbach, Patrick A Schweizer, et al.
Life Sciences|August 23, 2012
Enhancement of K2P2.1 (TREK1) background currents expressed in Xenopus oocytes by voltage-gated K+ channel β subunitsJana Kisselbach, Patrick A Schweizer, Rüdiger Gerstberger, et al.
Drugs Under Experimental and Clinical Research|January 1, 1989
The pharmacological profile of CGP 28238, a novel highly potent anti-inflammatory compoundI Wiesenberg-Boettcher, A Schweizer, J R Green, et al.
Journal of Cell Science|March 1, 1993
A reversibly palmitoylated resident protein (p63) of an ER-Golgi intermediate compartment is related to a circulatory shock resuscitation proteinA Schweizer, J Rohrer, P Jenö, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|May 21, 2011
Bilingualism as a contributor to cognitive reserve: evidence from brain atrophy in Alzheimer's diseaseTom A Schweizer, Jenna Ware, Corinne E Fischer, et al.
European Journal of Pharmacology|September 28, 2013
Class I antiarrhythmic drugs inhibit human cardiac two-pore-domain K(+) (K2 ₂p) channelsConstanze Schmidt, Felix Wiedmann, Patrick A Schweizer, et al.
Pageof 50